NCT05600738 Network Effects of Therapeutic Deep Brain Stimulation
| NCT ID | NCT05600738 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Intractable Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2022-08-26 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2022-08-26 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to map the acute, short-term cortical evoked responses to thalamic electrical stimulation in persons with intractable epilepsy
Eligibility Criteria
Inclusion Criteria: * diagnosis of Epilepsy * undergoing neuromodulation therapy with clinically implanted neuromodulation devices (DBS, RNS) * followed in the outpatient epilepsy clinic Exclusion Criteria: * pregnant women * active psychosis, major depression, or suicidal ideation in the preceding year * Intelligence quotient (IQ) less than 70 as measured by clinical neuropsychological evaluation * Do not agree to share their medical records for research purposes
Contact & Investigator
Sandipan Pati, MD
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center, Houston
Frequently Asked Questions
Who can join the NCT05600738 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intractable Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05600738 currently recruiting?
Yes, NCT05600738 is actively recruiting participants. Contact the research team at Sandipan.Pati@uth.tmc.edu for enrollment information.
Where is the NCT05600738 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT05600738 clinical trial?
NCT05600738 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Sandipan Pati, MD at The University of Texas Health Science Center, Houston. The trial plans to enroll 25 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.